JP2004534818A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004534818A5 JP2004534818A5 JP2003506904A JP2003506904A JP2004534818A5 JP 2004534818 A5 JP2004534818 A5 JP 2004534818A5 JP 2003506904 A JP2003506904 A JP 2003506904A JP 2003506904 A JP2003506904 A JP 2003506904A JP 2004534818 A5 JP2004534818 A5 JP 2004534818A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- alkoxy
- halogen
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10129714A DE10129714A1 (de) | 2001-06-22 | 2001-06-22 | Topische Anwendung von Thiazolylamiden |
| PCT/EP2002/006327 WO2003000259A1 (de) | 2001-06-22 | 2002-06-10 | Topische anwendung von thiazolylamiden |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004534818A JP2004534818A (ja) | 2004-11-18 |
| JP2004534818A5 true JP2004534818A5 (https=) | 2006-01-05 |
| JP4342304B2 JP4342304B2 (ja) | 2009-10-14 |
Family
ID=7688817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003506904A Expired - Lifetime JP4342304B2 (ja) | 2001-06-22 | 2002-06-10 | チアゾリルアミドの局所適用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7883713B2 (https=) |
| EP (2) | EP1629842B1 (https=) |
| JP (1) | JP4342304B2 (https=) |
| KR (1) | KR100899491B1 (https=) |
| CN (1) | CN1535149B (https=) |
| AT (2) | ATE320253T1 (https=) |
| AU (1) | AU2002345023B2 (https=) |
| BR (1) | BRPI0210601B8 (https=) |
| CA (1) | CA2451552C (https=) |
| DE (3) | DE10129714A1 (https=) |
| DK (2) | DK1629842T3 (https=) |
| ES (2) | ES2341778T3 (https=) |
| IL (1) | IL159258A0 (https=) |
| MX (1) | MXPA03011518A (https=) |
| PL (1) | PL208927B1 (https=) |
| PT (2) | PT1401435E (https=) |
| WO (1) | WO2003000259A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10129715A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Thiazolylamide |
| DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
| CN103269593A (zh) * | 2010-11-01 | 2013-08-28 | 罗马克实验室有限公司 | 烷基亚磺酰基取代的噻唑化物化合物 |
| EP2573086A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| EP2573085A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
| JP6918823B2 (ja) | 2016-04-06 | 2021-08-11 | イノベーティブ モレキュールズ ゲーエムベーハーＩｎｎｏｖａｔｉｖｅ Ｍｏｌｅｃｕｌｅｓ Ｇｍｂｈ | 抗ウイルス剤として有用なアミノチアゾール誘導体 |
| LT3544976T (lt) | 2016-11-28 | 2021-08-10 | Aicuris Gmbh & Co. Kg | N-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamido laisvos bazės hemihidratas, jo gamybos būdai ir panaudojimai |
| AR110251A1 (es) | 2016-11-28 | 2019-03-13 | Aicuris Anti Infective Cures Gmbh | Una sal maleato de la base libre de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, formulaciones farmacéuticas, métodos de fabricación y usos de la misma |
| AR110250A1 (es) * | 2016-11-28 | 2019-03-13 | Aicuris Anti Infective Cures Gmbh | Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida |
| WO2019068817A1 (en) | 2017-10-05 | 2019-04-11 | Innovative Molecules Gmbh | SUBSTITUTED THIAZOLEAN ENANTIOMERS AS ANTIVIRAL COMPOUNDS |
| EP3925595A1 (en) * | 2020-06-17 | 2021-12-22 | AiCuris GmbH & Co. KG | Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide hemihydrate |
| CA3168721A1 (en) * | 2020-03-26 | 2021-09-30 | Jessica Redmer | Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3- thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide hemihydrate |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA984848A (en) | 1970-01-16 | 1976-03-02 | Kurt H. Pilgram | Herbicides |
| US3658830A (en) * | 1970-01-16 | 1972-04-25 | Shell Oil Co | 5-(substituted mercapto sulfiny sulfonyl or sulfamoyl) |
| US3717651A (en) * | 1970-04-20 | 1973-02-20 | Shell Oil Co | Thiazoles |
| US3847588A (en) * | 1970-04-20 | 1974-11-12 | Shell Oil Co | Thiazoles herbicidal |
| GB2080682B (en) * | 1980-07-30 | 1984-03-28 | Ciba Geigy Ag | Antiherpetically active lipstick |
| US4556560A (en) * | 1983-01-24 | 1985-12-03 | The Procter & Gamble Company | Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis |
| DE3319282A1 (de) * | 1983-05-27 | 1984-11-29 | Gödecke AG, 1000 Berlin | Verwendung von adenosin bei der behandlung von herpes |
| ES2186811T3 (es) | 1995-12-29 | 2003-05-16 | Boehringer Ingelheim Pharma | Derivados de feniltiazol con propiedades anti-virus herpes. |
| GB2311069A (en) | 1996-03-14 | 1997-09-17 | Merck & Co Inc | Primase isolated from human cytomegalovirus (HCMV) |
| US5705344A (en) | 1996-03-14 | 1998-01-06 | Tularik, Inc. | High-throughput screening assay for inhibitors of nucleic acid helicases |
| GB2311068A (en) | 1996-03-14 | 1997-09-17 | Merck & Co Inc | Helicase isolated from human cytomegalovirus (HCMV) |
| CA2223032A1 (en) | 1997-02-21 | 1998-08-21 | Smithkline Beecham Corporation | Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents |
| DE19802437A1 (de) | 1998-01-23 | 1999-07-29 | Bayer Ag | Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe |
| AU3289299A (en) | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
| NZ507032A (en) | 1998-03-19 | 2003-06-30 | Pharmacia & Upjohn | 1,3,4-thiadiazoles useful for the treatment of herpes and cytomegalovirus infections |
| WO2000053591A1 (de) * | 1999-03-08 | 2000-09-14 | Bayer Aktiengesellschaft | Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel |
| DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
| EP1319185A1 (en) * | 2000-06-15 | 2003-06-18 | Bayer Aktiengesellschaft | Method for identifying compounds with anti-herpes activity |
| DE10129716A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Kombinationspräparate zur Herpes-Behandlung |
| DE10131128A1 (de) | 2001-06-28 | 2003-01-16 | Bayer Ag | Sekundäre Sulfonamide |
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
-
2001
- 2001-06-22 DE DE10129714A patent/DE10129714A1/de not_active Withdrawn
-
2002
- 2002-06-10 MX MXPA03011518A patent/MXPA03011518A/es active IP Right Grant
- 2002-06-10 US US10/481,680 patent/US7883713B2/en not_active Expired - Lifetime
- 2002-06-10 WO PCT/EP2002/006327 patent/WO2003000259A1/de not_active Ceased
- 2002-06-10 AU AU2002345023A patent/AU2002345023B2/en not_active Expired
- 2002-06-10 JP JP2003506904A patent/JP4342304B2/ja not_active Expired - Lifetime
- 2002-06-10 ES ES05024999T patent/ES2341778T3/es not_active Expired - Lifetime
- 2002-06-10 BR BRPI0210601A patent/BRPI0210601B8/pt not_active IP Right Cessation
- 2002-06-10 CN CN028125304A patent/CN1535149B/zh not_active Expired - Lifetime
- 2002-06-10 PL PL364378A patent/PL208927B1/pl unknown
- 2002-06-10 AT AT02743172T patent/ATE320253T1/de active
- 2002-06-10 PT PT02743172T patent/PT1401435E/pt unknown
- 2002-06-10 EP EP05024999A patent/EP1629842B1/de not_active Expired - Lifetime
- 2002-06-10 PT PT05024999T patent/PT1629842E/pt unknown
- 2002-06-10 ES ES02743172T patent/ES2260449T3/es not_active Expired - Lifetime
- 2002-06-10 DK DK05024999.4T patent/DK1629842T3/da active
- 2002-06-10 EP EP02743172A patent/EP1401435B1/de not_active Expired - Lifetime
- 2002-06-10 KR KR1020037016645A patent/KR100899491B1/ko not_active Expired - Fee Related
- 2002-06-10 DE DE50206084T patent/DE50206084D1/de not_active Expired - Lifetime
- 2002-06-10 DK DK02743172T patent/DK1401435T3/da active
- 2002-06-10 CA CA2451552A patent/CA2451552C/en not_active Expired - Lifetime
- 2002-06-10 IL IL15925802A patent/IL159258A0/xx active IP Right Grant
- 2002-06-10 DE DE50214378T patent/DE50214378D1/de not_active Expired - Lifetime
- 2002-06-10 AT AT05024999T patent/ATE464047T1/de active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2436780C2 (ru) | Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы | |
| JOP20220069A1 (ar) | عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها | |
| RU2348617C2 (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2004534818A5 (https=) | ||
| JP2016518437A5 (https=) | ||
| JP2005536475A5 (https=) | ||
| JP2010523570A5 (https=) | ||
| JP2010533160A5 (https=) | ||
| JP2005504042A5 (https=) | ||
| RU2017144495A (ru) | Противогельминтные депсипептидные соединения | |
| JP2008516986A5 (https=) | ||
| JP2006515858A5 (https=) | ||
| JP2019504050A5 (https=) | ||
| JP2019500387A5 (https=) | ||
| JP2018502906A5 (https=) | ||
| JP2013531070A5 (https=) | ||
| JP2019535723A5 (https=) | ||
| JP2007507494A5 (https=) | ||
| JP2004525183A5 (https=) | ||
| JP2018522861A5 (https=) | ||
| RU2435760C2 (ru) | 1н-хиназолин-2,4-дионы | |
| RU2011112684A (ru) | АГЕНТ, СПОСОБСТВУЮЩИЙ РОСТУ ВОЛОС, СОДЕРЖАЩИЙ В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА ПРОИЗВОДНОЕ 15,15-ДИФТОРПРОСТАГЛАНДИНА F2α | |
| JP2009501775A5 (https=) | ||
| JP2019196382A5 (https=) | ||
| JP2006516626A5 (https=) |